×
About 2,373 results

ALLMedicine™ Anal Cancer Center

Research & Reviews  783 results

Quality of Life and Sexual Function of Men Who Have Sex With Men Treated for Anal Cance...
https://doi.org/10.1016/j.jsxm.2021.05.015
The Journal of Sexual Medicine; Mauro GP, da Conceição Vasconcelos KGM et. al.

Jul 13th, 2021 - Anal cancer is a rare disease, more prevalent in women. Men who have sex with men (MSM) are a high-risk neglected population. The primary objective was to assess quality of life (QoL) and sexual function (SxF) among MSM treated with radical chemor...

The association between protease inhibitors and anal cancer outcomes in veterans living...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256603
BMC Cancer; Yoder AK, Lakomy DS et. al.

Jul 6th, 2021 - The incidence of anal squamous cell carcinoma has been increasing, particularly in people living with HIV (PLWH). There is concern that radiosensitizing drugs, such as protease inhibitors, commonly used in the management of HIV, may increase toxic...

Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a rando...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245463
BMJ Open; Nyitray AG, Schick V et. al.

Jun 30th, 2021 - Squamous cell carcinoma of the anus is a common cancer among sexual minority men, especially HIV-positive sexual minority men; however, there is no evidenced-based national screening protocol for detection of anal precancers. Our objective is to d...

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
https://doi.org/10.1016/j.annonc.2021.06.015
Annals of Oncology : Official Journal of the European Soc... Rao S, Guren MG et. al.

Jun 27th, 2021 - Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2021|Rao S,Guren MG,Khan K,Brown G,Renehan AG,|

Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicen...
https://doi.org/10.1016/j.clcc.2021.05.005
Clinical Colorectal Cancer; Mattos BRS, Camandaroba MPG et. al.

Jun 23rd, 2021 - HIV-positive patients are underrepresented in clinical trials of metastatic squamous cell carcinoma of the anal canal (mSCCA). We aimed to compare the clinical outcomes of mSCCA patients according to HIV infection. This was a retrospective multice...

see more →

Guidelines  7 results

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
https://doi.org/10.1016/j.annonc.2021.06.015
Annals of Oncology : Official Journal of the European Soc... Rao S, Guren MG et. al.

Jun 27th, 2021 - Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2021|Rao S,Guren MG,Khan K,Brown G,Renehan AG,|

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in ...
https://doi.org/10.6004/jnccn.2018.0066
Journal of the National Comprehensive Cancer Network : JN... Reid E, Suneja G et. al.

Aug 13th, 2018 - People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the general population and generally have a higher mortality due to delayed diagnoses, advanced cancer stage, comorbidities, immunosuppression, and cancer treatment ...

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2018.0060
Journal of the National Comprehensive Cancer Network : JN... Benson AB, Venook AP et. al.

Jul 14th, 2018 - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain les...

2016 IANS International Guidelines for Practice Standards in the Detection of Anal Canc...
https://doi.org/10.1097/LGT.0000000000000256
Journal of Lower Genital Tract Disease; Hillman RJ, Cuming T et. al.

Aug 25th, 2016 - To define minimum standards for provision of services and clinical practice in the investigation of anal cancer precursors. After initial face to face meetings of experts at the International Papillomavirus meeting in Lisbon, September 17 to 21, 2...

Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and ...
https://doi.org/10.1093/annonc/mdu159
Annals of Oncology : Official Journal of the European Soc... Glynne-Jones R, Nilsson PJ et. al.

Jul 8th, 2014 - Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2014|Glynne-Jones R,Nilsson PJ,Aschele C,Goh V,Peiffert D,|diagnosis,therapy,standards,

see more →

Drugs  2 results see all →

Clinicaltrials.gov  45 results

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
https://clinicaltrials.gov/ct2/show/NCT03233711

May 4th, 2020 - PRIMARY OBJECTIVE: I. To evaluate whether therapy with nivolumab following combined modality therapy (CMT) improves disease-free survival (DFS) compared with observation in patients with high risk anal carcinoma. SECONDARY OBJECTIVES: I. To compar...

Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
https://clinicaltrials.gov/ct2/show/NCT03386500

Apr 26th, 2020 - In this Phase 1/2 study, the investigators will conduct a safety and efficacy study of the combination of BMX-001 with standard radiation therapy (RT) and concurrent 5-fluorouracil (5FU)/mitomycin in newly diagnosed Anal Squamous Cell Carcinoma (A...

QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
https://clinicaltrials.gov/ct2/show/NCT00568425

Apr 8th, 2020 - The objectives of this study are three-fold. First, we would like to learn and compare the doses of radiation received by the tumor and the normal tissues in anal cancer patients treated with IMRT, and in those treated with conventional radiothera...

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
https://clinicaltrials.gov/ct2/show/NCT02437851

Mar 31st, 2020 - PRIMARY OBJECTIVES: I. To define the proportion of participants who develop treatment failure at 2 years, defined as the occurrence of distant or any nodal metastases or recurrence of cancer requiring chemotherapy (CMT), defined as a cancer that n...

Seville Cohort of People Living With HIV at Risk for Anal Cancer
https://clinicaltrials.gov/ct2/show/NCT03713229

Jan 17th, 2020 - The development of anal precancerous squamous intraepithelial lesions (SIL) and cancer of the anus is mainly caused by infection with high-risk human papillomavirus genotypes (HR-HPV). There is increasing awareness of marked (40 to 130-fold) risk ...

see more →

News  105 results

Call to Eradicate All Types of HPV Cancers, not Just Cervical
https://www.medscape.com/viewarticle/948120

Mar 24th, 2021 - The World Health Organization's (WHO) call for the elimination of cervical cancer worldwide is a laudable goal, and one that many organizations across the globe have endorsed. Yet some would say that that goal goes only halfway, and that the real ...

The Vanguard of HIV Care: Don't Forget This Screening
https://www.medscape.com/viewarticle/946148

Feb 21st, 2021 - HIV-positive patients who are adherent with antiretroviral medications are achieving undetectable or very low levels of HIV viremia and living longer. In response, clinical care is continually adapting to the dramatically altered natural history o...

Adults With HIV at Increased Risk for Anal Carcinoma After Anogenital Warts
https://www.medscape.com/viewarticle/944579

Jan 24th, 2021 - (Reuters Health) - Adults living with HIV who have a history of anogenital warts may be at increased risk for developing anal carcinoma, a recent study suggests. Researchers examined data on 6,515 adults living with HIV who received care at one of...

'Reshaping' Radiotherapy May Reduce Female Sexual Dysfunction
https://www.medscape.com/viewarticle/940447

Nov 4th, 2020 - Radiotherapy plays an important role in the treatment of anal cancer, but many female survivors treated with pelvic radiotherapy develop long-term sexual problems. A new study shows that it is possible to reduce the dose of radiation reaching the ...

Combo Carboplatin/Paclitaxel New Standard of Care for Anal Cancer
https://www.staging.medscape.com/viewarticle/932971

Jun 24th, 2020 - UPDATED with comments  June 25, 2020 // This story has been updated with comments about the study from Dr Michael Buckstein. Carboplatin plus paclitaxel should now be considered the standard of care for patients with advanced anal cancer, in place...

see more →

Patient Education  7 results see all →